Skip to content
PIL Logo

Mirtazapine 15mg Film-coated Tablets*

Last Updated on eMC 14-Sep-2017 View changes  | Actavis UK Ltd Contact details

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the link to the left to view the PIL in PDF format.

Related Info
VIEW

Product information - Two Actavis Mirtazapine 15mg Tablet licences currently in circulation

Two Actavis Mirtazapine 15mg Tablet licences are currently in circulation. Mirtazapine 15mg Tablets are no longer being marketed under PL 30306/0170 and stock is currently being supplied with PL 30306/0643. For some time there will be both licences in circulation, therefore please consult the PL number on the outer carton and section 8 of the SPC to ensure you are looking at the correct SPC. For more information please contact Actavis Medical Information on 01271 385 257 or email Medinfo@accord-healthcare.com

CLOSE THIS PANEL

Company contact details

Company image
Address

Actavis UK Ltd, a subsidiary of Accord Healthcare Ltd, Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK

Fax

+44 (0)1271 346 106

Medical Information e-mail
Telephone

+44 (0)1271 385 200

Medical Information Direct Line

+44 (0)1271 385 257

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

mirtazapine

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue